Literature DB >> 25870755

Structure of a TLR4-interacting SPA4 peptide.

Shanjana Awasthi1, Asokan Anbanandam2, Karla K Rodgers3.   

Abstract

We have recently identified a Toll-like receptor (TLR4)-interacting SPA4 peptide encoding amino acids: GDFRYSDGTPVNYTNWYRGE, a shorter region of human surfactant protein-A (SP-A). The SPA4 peptide suppressed lipopolysaccharide-induced inflammation (JPET 2011, Innate Immun 2013). In this report, we examined the structure of synthetic SPA4 peptide in solution by circular dichroism (CD) and nuclear magnetic resonance (NMR) spectroscopy. The CD analysis revealed that the SPA4 peptide is composed of ∼35% beta sheet and <5% alpha helix. We used solution NMR to solve the structure of the SPA4 peptide. We calculated NMR structures using Nuclear Overhauser Enhancement (NOE) distance restraints. The superposition of the low energy structures indicated that the central 6-14 amino acids "SDGTPVNYT" of the 20mer SPA4 peptide form a turn, and amino acids on either side (GDFRY and NWYRGE) conform to flexible arms. Furthermore, thermal denaturation experiments demonstrated the structural flexibility of the peptide. The NMR structures of the SPA4 peptide align well with the homologous region within the available structure of rat SP-A and a computationally-docked model of SP-A-TLR4-MD2 protein complex. Together, our results support the structural adaptability of SPA4 peptide for binding to TLR4.

Entities:  

Keywords:  Surfactant protein-A-derived peptide; Toll-like receptor-4; structure

Year:  2015        PMID: 25870755      PMCID: PMC4392768          DOI: 10.1039/C4RA16731G

Source DB:  PubMed          Journal:  RSC Adv        ISSN: 2046-2069            Impact factor:   3.361


  20 in total

Review 1.  Surfactant Protein A: regulation of innate and adaptive immune responses in lung inflammation.

Authors:  J R Wright; P Borron; K G Brinker; R J Folz
Journal:  Am J Respir Cell Mol Biol       Date:  2001-05       Impact factor: 6.914

2.  By binding SIRPalpha or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation.

Authors:  Shyra J Gardai; Yi-Qun Xiao; Matthew Dickinson; Jerry A Nick; Dennis R Voelker; Kelly E Greene; Peter M Henson
Journal:  Cell       Date:  2003-10-03       Impact factor: 41.582

3.  UCSF Chimera--a visualization system for exploratory research and analysis.

Authors:  Eric F Pettersen; Thomas D Goddard; Conrad C Huang; Gregory S Couch; Daniel M Greenblatt; Elaine C Meng; Thomas E Ferrin
Journal:  J Comput Chem       Date:  2004-10       Impact factor: 3.376

4.  NMRPipe: a multidimensional spectral processing system based on UNIX pipes.

Authors:  F Delaglio; S Grzesiek; G W Vuister; G Zhu; J Pfeifer; A Bax
Journal:  J Biomol NMR       Date:  1995-11       Impact factor: 2.835

Review 5.  Pulmonary surfactant.

Authors:  R J King
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1982-07

6.  A toll-like receptor-4-interacting surfactant protein-A-derived peptide suppresses tumor necrosis factor-α release from mouse JAWS II dendritic cells.

Authors:  Shanjana Awasthi; Kevin Brown; Catherine King; Vibhudutta Awasthi; Rajkumar Bondugula
Journal:  J Pharmacol Exp Ther       Date:  2010-12-15       Impact factor: 4.030

7.  Glycoprotein-340 binds surfactant protein-A (SP-A) and stimulates alveolar macrophage migration in an SP-A-independent manner.

Authors:  M J Tino; J R Wright
Journal:  Am J Respir Cell Mol Biol       Date:  1999-04       Impact factor: 6.914

Review 8.  Pulmonary surfactant: an immunological perspective.

Authors:  Zissis C Chroneos; Zvjezdana Sever-Chroneos; Virginia L Shepherd
Journal:  Cell Physiol Biochem       Date:  2009-12-22

9.  Crystal structure of trimeric carbohydrate recognition and neck domains of surfactant protein A.

Authors:  James F Head; Tanya R Mealy; Francis X McCormack; Barbara A Seaton
Journal:  J Biol Chem       Date:  2003-08-11       Impact factor: 5.157

Review 10.  Toll-like receptor 4 activation in cancer progression and therapy.

Authors:  Alja Oblak; Roman Jerala
Journal:  Clin Dev Immunol       Date:  2011-11-03
View more
  4 in total

1.  Lung and general health effects of Toll-like receptor-4 (TLR4)-interacting SPA4 peptide.

Authors:  Shanjana Awasthi; Negar Rahman; Bin Rui; Gaurav Kumar; Vibhudutta Awasthi; Melanie Breshears; Stanley Kosanke
Journal:  BMC Pulm Med       Date:  2020-06-23       Impact factor: 3.317

2.  Effects of SPA4 peptide on lipopolysaccharide-disrupted lung epithelial barrier, injury, and function in a human cell system and mouse model of lung injury.

Authors:  Asif Alam Chowdhury; Nachiket M Godbole; Neha Chataut; Stanley Kosanke; Karla Rodgers; Shanjana Awasthi
Journal:  Physiol Rep       Date:  2022-07

3.  TLR4-interacting SPA4 peptide improves host defense and alleviates tissue injury in a mouse model of Pseudomonas aeruginosa lung infection.

Authors:  Shanjana Awasthi; Bhupinder Singh; Vijay Ramani; Jun Xie; Stanley Kosanke
Journal:  PLoS One       Date:  2019-01-28       Impact factor: 3.240

4.  Mechanism of Anti-Inflammatory Activity of TLR4-Interacting SPA4 Peptide.

Authors:  Shanjana Awasthi; Gaurav Kumar; Vijay Ramani; Vibhudutta Awasthi; Karla K Rodgers; Jun Xie; Jacob Beierle; Gertrude Kyere-Davies; Bhupinder Singh; Negar Rahman; Asif Alam Chowdhury; Neha Chataut
Journal:  Immunohorizons       Date:  2021-08-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.